Is Larazotide FDA approved?
No. This profile records Larazotide as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE GUT SEALER
AT-1001; Larazotide Acetate
Larazotide is designed to close the gaps between intestinal cells that cause "leaky gut." It blocks zonulin, a protein that opens these gaps and allows food particles and bacteria to leak into your bloodstream. Originally developed for celiac disease, it may help anyone with intestinal permeability issues.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
May 8, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records Larazotide as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 0.5-1 mg three times daily before meals.
Schedule: daily. Cycle: Ongoing for gut barrier support. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Prevents zonulin from opening tight junctions
Keeps intestinal cells tightly connected
Reduces immune activation from leaked antigens
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.